XTL Biopharmaceuticals Ltd. Extraordinary General Meetings Postponed Until March 18, 2009
12 March 2009 - 2:05AM
PR Newswire (US)
VALLEY COTTAGE, N.Y., March 11 /PRNewswire-FirstCall/ -- XTL
Biopharmaceuticals Ltd. (NASDAQ:XTLB)(TASE:XTL) announced today
that its Extraordinary General Meetings ("EGMs") were postponed for
one week in accordance with its articles of association due to the
absence of a quorum. The postponed EGMs will take place at the
Company, Building 3, Kiryat Weizmann Science Park, Rehovot, Israel
76100 at 3:00 p.m. and 5:30 p.m. Israel time on March 18, 2009. Any
proxy votes received at any time up to 48 hours prior to the
postponed EGM will be included in the total votes counted for the
EGMs. Those shareholders who have a valid "proof of ownership" in
Israel or a letter of representation from Computershare, the
Company's UK registrars, or a letter of representation from the
Bank of NY for an ADR owner, and attend the meeting in person will
also be permitted to vote. DATASOURCE: XTL Biopharmaceuticals Ltd.
CONTACT: Ron Bentsur, Co-Chief Executive Officer, +1-845-267-0707
ext. 224
Copyright
XTL Biopharmaceuticals (NASDAQ:XTLB)
Historical Stock Chart
From Jun 2024 to Jul 2024
XTL Biopharmaceuticals (NASDAQ:XTLB)
Historical Stock Chart
From Jul 2023 to Jul 2024
